Caren Deardorf - Sep 14, 2021 Form 4 Insider Report for Magenta Therapeutics, Inc. (MGTA)

Role: Chief Commercial Officer
Signature: /s/ Thomas W. Beetham, Attorney-in-Fact for Caren Deardorf
Stock symbol: MGTA
Transactions as of: Sep 14, 2021
Transactions value $: $0
Form type: 4
Date filed: 9/16/2021, 07:41 PM
Previous filing: Jul 8, 2021
Next filing: Sep 20, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MGTA	Common Stock	Award	$0	+20K		$0.00	20K	Sep 14, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 6, 2021, the reporting person was granted 40,000 restricted stock units. The restricted stock units vest in two equal installments subject to the achievement of certain performance milestones related to the issuer's business plans. The first performance milestone was achieved, resulting in vesting of 20,000 restricted stock units and the corresponding issuance of 20,000 shares of issuer common stock.

Content

On July 6, 2021, the reporting person was granted 40,000 restricted stock units. The restricted stock units vest in two equal installments subject to the achievement of certain performance milestones related to the issuer's business plans. The first performance milestone was achieved, resulting in vesting of 20,000 restricted stock units and the corresponding issuance of 20,000 shares of issuer common stock.